These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. A new rating scale for negative symptoms: the Motor-Affective-Social Scale. Trémeau F; Goggin M; Antonius D; Czobor P; Hill V; Citrome L Psychiatry Res; 2008 Sep; 160(3):346-55. PubMed ID: 18722021 [TBL] [Abstract][Full Text] [Related]
25. Heterogeneity in schizophrenia: an extended replication of the hebephrenic-like and paranoid-like subtypes. Williams J; Farmer AE; Wessely S; Castle DJ; McGuffin P Psychiatry Res; 1993 Dec; 49(3):199-210. PubMed ID: 8177916 [TBL] [Abstract][Full Text] [Related]
27. Statistical evaluation of the Treatment Response Assessment Method (TRAM) for psychiatric disorders. Frosch WA; Hekimian LJ; Warwick KM; Friedhoff AJ J Clin Pharmacol J New Drugs; 1969; 9(2):83-90. PubMed ID: 5253272 [No Abstract] [Full Text] [Related]
28. Correlates of a depressive typology. Paykel ES Arch Gen Psychiatry; 1972 Aug; 27(2):203-10. PubMed ID: 5042827 [No Abstract] [Full Text] [Related]
29. Some contributions to the measurement of psychopathology. Fleiss JL; Gurland BJ; Cooper JE Br J Psychiatry; 1971 Dec; 119(553):647-56. PubMed ID: 5143665 [No Abstract] [Full Text] [Related]
30. Intelligence and neurosis in old age. Nunn C; Bergmann K; Britton PG; Foster EM; Hall EH; Kay DW Br J Psychiatry; 1974 May; 124(0):446-52. PubMed ID: 4836374 [No Abstract] [Full Text] [Related]
32. Major psychotic disorders. A cross-cultural study. Lorr M; Klett CJ Arch Gen Psychiatry; 1968 Dec; 19(6):652-8. PubMed ID: 5723310 [No Abstract] [Full Text] [Related]
33. [Abuse of psychoactive drugs and social adjustment of psychotic patients]. Lépine A; Côté G Can J Psychiatry; 1998 Dec; 43(10):1036-9. PubMed ID: 9868570 [TBL] [Abstract][Full Text] [Related]
35. Comparison of depression inventories in a clinical population. Schnurr R; Hoaken PC; Jarrett FJ Can Psychiatr Assoc J; 1976 Nov; 21(7):473-6. PubMed ID: 1016929 [No Abstract] [Full Text] [Related]
36. Assessing clinical significance of treatment outcomes using the DASS-21. Ronk FR; Korman JR; Hooke GR; Page AC Psychol Assess; 2013 Dec; 25(4):1103-10. PubMed ID: 23730826 [TBL] [Abstract][Full Text] [Related]
37. Subtle-obvious scales of the MMPI: indicators of profile validity in a psychiatric population. Brems C; Johnson ME J Pers Assess; 1991 Jun; 56(3):536-44. PubMed ID: 1865310 [TBL] [Abstract][Full Text] [Related]
38. Anxiety symptoms in schizophrenia spectrum disorders: associations with social function, positive and negative symptoms, hope and trauma history. Lysaker PH; Salyers MP Acta Psychiatr Scand; 2007 Oct; 116(4):290-8. PubMed ID: 17803759 [TBL] [Abstract][Full Text] [Related]
39. Associations Between the Rotter Incomplete Sentences Blank and Measures of Personality and Psychopathology. Torstrick A; McDermut W; Gokberk A; Bivona T; Walton KE J Pers Assess; 2015; 97(5):494-505. PubMed ID: 25803203 [TBL] [Abstract][Full Text] [Related]
40. [Psychiatric classification by means of a discriminatory application of Q factor analysis (author's transl)]. Schubö W; Hentschel U; Zerssen Dv; Mombour W Arch Psychiatr Nervenkr (1970); 1975 Sep; 220(3):187-200. PubMed ID: 1180690 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]